MSOs

Selling Weed Is Like A Sneaker Drop: Running Out Isn't A Problem For This Company
Cannabis Stocks Pop Following Chris Christie's Prediction That Trump Will Deschedule Cannabis
AdvisorShares MSOS Climbs 8% As Cannabis Rescheduling Sparks Investor Interest
Cannabis Stocks Pop Following Chris Christie's Prediction That Trump Will Deschedule Cannabis
AdvisorShares MSOS Climbs 8% As Cannabis Rescheduling Sparks Investor Interest
Almost Every Major Cannabis Company Could See Positive Cash Flow If 280E Is Removed In 2025
Canadian Cannabis Companies Are More Valuable Than Rivals In The U.S. - Here's Why

MSOs Recent News

Dazed By The Cannabis ETF Whirlwind? Here Is A Short Guide To Survival
Explore the volatile cannabis ETFs market, trends, disparities, and the future landscape. Expert insights reveal investment strategies.
The Highs And Lows Of Cannabis Stocks In 2023: A Year In Review
Explore the 2023 journey of cannabis stocks, contrasting U.S. struggles with Canadian market stability and investor insights.
The Billion-Dollar Question: How Much Are Cannabis Multi-State Operators Really Worth?
In his latest note, senior analyst Pablo Zuanic from equity research firm Zuanic & Associates assesses the valuation of US Multi-State Operators (MSOs) in the cannabis sector.
Cannabis Industry Sales Trends: Is Momentum Building or Slowing? A State-By-State Analysis For 3Q23
Is the cannabis industry losing steam or gaining momentum?
Breaking: Unwinding Poseidon Cannabis ETF, Managing Partner Drops Exclusive Insights
In a recent episode of Benzinga Cannabis Insider, Morgan Paxhia, co-founder and managing partner of Poseidon Investment Management dropped a bombshell that is sending shockwaves through the cannabis investment community.
Cannabis Chart of the Week: How Aggressive Are 2nd Quarter EBITDA Margin Estimates?
The chart shows analyst estimates of EBITDA margins for the second quarter vs. the first quarter and the 2nd quarter of 2022 for the fourteen largest MSOs for which we have consistent analyst projections.
Cannabis Chart Of The Week: Rule 280e – Taxation Without Representation?
In honor of Independence Day, the Viridian Capital Chart of the Week explores the impact of IRS Rule 280e, the most egregious tax leveled on any American industry, posing an existential threat to even some of the largest MSOs.
Cannabis Chart Of The Week: Analysts Have Reasonable Expectations, Leaving Room For Upside Surprises
The graph depicts consensus analyst expectations for the ten largest MSOs that have consistent 2023 and 2024 estimates, including Curaleaf (OTC: CURLF), Green Thumb (OTC: GTBIF), Verano (OTC:
Cannabis MSOS 2023 Debt Cliff Concerns Overblown—Most Debt Matures In 2024 & Beyond
There’s been some talk about potential ‘debt cliff’ concerns facing U.S. cannabis multi-state operators (MSOs) in 2023. The theory goes that publicly-traded companies struggling on the capital markets, and with cash balances contracting due to continuing net losses (with few exceptions), MSOs will have difficulty making principal payments on maturing debt coming due.
Analyst: How Do Virginia's Delayed Cannabis Sales Impact Important Deals For These Three MSOs?
Virginia is approaching its second anniversary of legalizing recreational cannabis without a framework for legal sales as yet established.
Ten Multistate Cannabis Companies Owe $500M To The IRS, Says A New Report
An analysis of financial filings by Green Market Report showed that ten publicly traded multistate cannabis companies are carrying over $500 million in federal tax debts.
Cannabis M&A: How MSOs Evaluate Brands To Acquire
This article was originally published on WeedWeek and appears here with permission.
Family-Run Nightshade Farm Seeks Strategic Partner As MSOs Scoop Up NY Cannabis Licenses
As New York gets closer to launching a recreational cannabis program, it's proving to be fertile ground for large multi-state operators (MSOs) like Curaleaf (OTCQX: CUR
Harvest Health & Recreation Buys Verano Holdings In $850M All-Stock Deal

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved